Carlyle Group is looking to secure debt funding of at least $2.5bn to support its potential acquisition of stakes in some of medical device maker Medtronic’s business units, according to a report by Bloomberg.
The report cites unnamed sources familiar with the matter as confirming that the private investment major is in ‘dual track’ talks with both Wall Street banks and private credit lenders over the funding.
According to Bloomberg’s sources, talks over the debt packages are at an early and could change as Carlyle looks to secure funding for a potential $7bn deal to acquire majority stakes in two of Medtronic’s units.
